Gregoriadis G, Meehan A, Mah M M
Biochem J. 1981 Nov 15;200(2):203-10. doi: 10.1042/bj2000203.
Affinity chromatography-purified and non-purified rabbit immunoglobulin G (IgG) raised against human immunoglobulin M (IgM) or kappa chain was incorporated into carboxyfluorescein-containing small unilamellar liposomes composed of egg phosphatidylcholine, cholesterol and phosphatidic acid (molar proportions 7:7:1). IgG incorporation was carried out by co-sonicating the immunoglobulin with the lipids (30% incorporated) (method A) or by interacting it with preformed liposomes bearing goat anti-(rabbit IgG) IgG (63 and 70% incorporated) (method B). (1) Judging from liposomal carboxyfluorescein-latency values, incorporation of IgG by either method did not affect liposomal stability. Furthermore, treatment of liposomes with papain released 75.1% (method A) and 93.3% and 95.1% (method B) of the IgG, suggesting that most of its antigen-recognizing Fab regions were available on the liposomal surface. This was strongly supported by the immunoelectrophoretic detection of Fab in papain-released products. (2) Liposomes bearing purified anti-IgM IgG bound 30%, (method A) and 45% (method B) of IgM in buffer. These values wee about 6-fold greater (both methods) than those obtained with corresponding liposomes bearing non-purified IgG. Binding of liposomes bearing anti-(kappa chain) IgG to kappa chain in buffer was 37% of that added. In the presence of mouse blood or serum, binding of IgM to liposomes bearing purified anti-IgM IgG was decreased slightly (24 and 30% for methods A and B). However, because of the nearly complete abolition of IgM binding to liposomes bearing non-purified IgG, these values were now 20-25-fold greater than those obtained with liposomes bearing non-purified IgG. (3) In mice pre-injected with IgM, at least 36.1% and 37.7% of the antigen was bound to subsequently injected liposomes bearing anti-IgM IgG incorporated by methods A and B respectively. No binding occurred with liposomes bearing the non-purified IgG. (4) Cholesterol-rich small unilamellar liposomes bearing affinity chromatography-purified antibodies may prove useful for the specific binding of free antigens in vivo.
将针对人免疫球蛋白M(IgM)或κ链产生的亲和层析纯化及未纯化的兔免疫球蛋白G(IgG)掺入由鸡蛋磷脂酰胆碱、胆固醇和磷脂酸(摩尔比7:7:1)组成的含羧基荧光素的小单层脂质体中。IgG的掺入通过将免疫球蛋白与脂质共同超声处理(掺入率30%)(方法A)或使其与带有山羊抗(兔IgG)IgG的预先形成的脂质体相互作用(掺入率63%和70%)(方法B)来进行。(1)从脂质体羧基荧光素潜伏值判断,两种方法掺入IgG均不影响脂质体稳定性。此外,用木瓜蛋白酶处理脂质体可释放75.1%(方法A)以及93.3%和95.1%(方法B)的IgG,这表明其大部分抗原识别Fab区域可在脂质体表面获得。木瓜蛋白酶释放产物中Fab的免疫电泳检测有力地支持了这一点。(2)带有纯化抗IgM IgG的脂质体在缓冲液中结合了30%(方法A)和45%(方法B)的IgM。这些值比相应的带有未纯化IgG的脂质体获得的值大约高6倍(两种方法均如此)。带有抗(κ链)IgG的脂质体在缓冲液中与κ链的结合为添加量的37%。在存在小鼠血液或血清的情况下,IgM与带有纯化抗IgM IgG的脂质体的结合略有下降(方法A和B分别为24%和30%)。然而,由于IgM与带有未纯化IgG的脂质体的结合几乎完全消除,这些值现在比带有未纯化IgG的脂质体获得的值大20 - 25倍。(3)在预先注射了IgM的小鼠中,分别至少有36.1%和37.7%的抗原与随后注射的通过方法A和B掺入抗IgM IgG的脂质体结合。带有未纯化IgG的脂质体未发生结合。(4)带有亲和层析纯化抗体的富含胆固醇的小单层脂质体可能证明对体内游离抗原的特异性结合有用。